Intimation of the publication of Financial Results for the quarter ended June 30, 2025 in the Newspaper - Financial Express (English) and Navshakti (Marathi).
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novartis India has informed the BSE that it published its unaudited financial results for the quarter ended June 30, 2025 in two newspapers on July 30, 2025 — Financial Express (English edition) and Navshakti (Marathi edition). This disclosure is being made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, which requires listed companies to publish quarterly results in newspapers. The intimation was signed by Chandni Maru, Company Secretary and Compliance Officer. The company did not share any specific financial numbers in this filing — it only confirms that the newspaper advertisements were published as mandated.
This is a routine regulatory compliance filing with no new financial information, so it is unlikely to move the stock price on its own. Investors should look at the actual Q1 FY26 results (separately filed with the exchanges) for any meaningful updates on revenue, profit, or business outlook.